By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Lysosomal enzymes > Elelyso
Lysosomal enzymes

Elelyso

https://themeditary.com/drug/elelyso-1578.html
Medically Reviewed by Philip Thornton, DipPharm TheMediTary.Com | Reviewed: Jul 13, 2023  Additional Content by TheMediTary.Com

Generic name: taliglucerase alfa [ tal-i-gloo-ser-ase-al-fa ]

Drug class: Lysosomal enzymes

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Brand names: Taliglucerase alfa

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Elelyso?

Elelyso is a man-made form of an enzyme that occurs naturally in the body. It is used as an enzyme replacement in adults and children at least 4 years old with Type I Gaucher disease.

Gaucher disease is a genetic condition in which the body lacks the enzyme needed to break down certain fatty materials (lipids). Lipids can build up in the body, causing symptoms such as easy bruising or bleeding, weakness, anemia, bone or joint pain, enlarged liver or spleen, or weakened bones that are easily fractured.

Elelyso may improve the condition of the liver, spleen, bones, and blood cells in people with Type I Gaucher disease. However, Elelyso is not a cure for this condition.

Warnings

Some people receiving a Elelyso injection have had a reaction when the medicine was injected, or up to 3 hours later. Tell your caregivers right away if you have a sudden headache, dizziness, warmth or tingling, chest pain, wheezing, nausea, or a red skin rash.

Elelyso is not a cure for Gaucher disease.

Before taking this medicine

You should not use Elelyso if you are allergic to taliglucerase alfa.

Tell your doctor if you are pregnant. It is not known whether taliglucerase alfa will harm an unborn baby. However, having untreated or uncontrolled Type I Gaucher disease during pregnancy may cause new or worsening symptoms in the mother, or complications in the baby such as growth problems or bleeding. The benefit of treating your disease may outweigh any risks to the baby.

It may not be safe to breastfeed while using Elelyso . Ask your doctor about any risk.

Elelyso pregnancy and breastfeeding warnings (more detail)

How should I take Elelyso

Elelyso is injected into a vein through an IV. A healthcare provider will give you this injection.

You may be given other medications to help prevent an allergic reaction. Keep using these medicines for as long as your doctor has prescribed.

You may be given other medications to prevent certain side effects of Elelyso.

Elelyso is usually given every other week. Follow your doctor's dosing instructions very carefully.

Your doctor may occasionally change your dose to make sure you get the best results.

Taliglucerase alfa doses are based on weight (especially in children and teenagers). Your dose needs may change if you gain or lose weight.

Dosing information

Usual Adult Dose of Elelyso for Gaucher Disease:

Therapy-naive patients: 60 units/kg via IV infusion (administered over 60 to 120 minutes) every other week

Patients switching from imiglucerase:
-Patients currently being treated with imiglucerase for type 1 Gaucher disease can be switched to this drug.
-Patients previously receiving a stable dose of imiglucerase should begin this drug at that same dose when they switch from imiglucerase to taliglucerase alfa.
-Dose adjustments can be made based on achievement and maintenance of each patient's therapeutic goals.
-A clinical study evaluated doses ranging from 9.5 to 60 units/kg IV every other week.

Use: For long-term enzyme replacement therapy (ERT) for patients with confirmed diagnosis of type 1 Gaucher disease

Usual Pediatric Dose of Elelyso for Gaucher Disease:

4 years or older:
Therapy-naive patients: 60 units/kg via IV infusion (administered over 60 to 120 minutes) every other week

Patients switching from imiglucerase:
-Patients currently being treated with imiglucerase for type 1 Gaucher disease can be switched to this drug.
-Patients previously receiving a stable dose of imiglucerase should begin this drug at that same dose when they switch from imiglucerase to taliglucerase alfa.
-Dose adjustments can be made based on achievement and maintenance of each patient's therapeutic goals.
-A clinical study evaluated doses ranging from 9.5 to 60 units/kg IV every other week.

Use: For long-term enzyme ERT for patients with confirmed diagnosis of type 1 Gaucher disease

Detailed Elelyso dosage information
Elelyso Dosage information (more detail)

Before Taking

You should not use Elelyso if you are allergic to taliglucerase alfa.

Tell your doctor if you are pregnant. It is not known whether taliglucerase alfa will harm an unborn baby. However, having untreated or uncontrolled Type I Gaucher disease during pregnancy may cause new or worsening symptoms in the mother, or complications in the baby such as growth problems or bleeding. The benefit of treating your disease may outweigh any risks to the baby.

It may not be safe to breastfeed while using Elelyso . Ask your doctor about any risk.

Elelyso pregnancy and breastfeeding warnings (more detail)

Related/similar drugs

Cerezyme, Cerdelga, eliglustat, miglustat

What happens if I miss a dose?

Call your doctor for instructions if you miss an appointment for your Elelyso injection.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while using Elelyso?

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

Elelyso side effects

Get emergency medical help if you have any signs of an allergic reaction to Elelyso: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Some people receiving a Elelyso injection have had a reaction when the medicine was injected, or up to 3 hours later. Tell your caregivers right away if you have:

  • dizziness or feeling like you might pass out;

  • chest tightness, wheezing;

  • swelling in your face;

  • cough, throat irritation;

  • flushing (warmth, redness, or tingly feeling);

  • nausea, vomiting; or

  • skin rash, itching, or redness.

Common Elelyso side effects may include:

  • headache;

  • rash, itching, warmth or tingly feeling;

  • dizziness or tired feeling;

  • nausea, stomach pain, vomiting; or

  • joint pain, back pain, pain in your arms or legs.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See more: Elelyso Side Effects

More about Elelyso (Taliglucerase alfa [ tal-i-gloo-ser-ase-al-fa ])

Dosage information
Elelyso Side Effects
During pregnancy
Drug images
Side effects
Drug class: Lysosomal enzymes

Related treatment guides

Gaucher Disease
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by